Clinical Trials on Progesterone Receptor Polymorphism
Total 0 results
Nothing found
Sponsors and Collaborators
- John Granton
- Mitchell Scheiman
- Wushan County People's Hospital
- Jeffrey Rudolph
- Northern California Melanoma Center
- Rex Bionics Plc
- Honda R and D Americas, Inc.
- CTC Bio, Inc.
- Zahra Rabbani Khah
- European Network For Smoking and Tobacco Prevention
- Marilia Medicine School
- Kawin Technology Share-holding Co., Ltd.
- Medtronic Atrial Fibrillation Solutions
- The Third Hospital of Changsha
- Montreal Neurological Institute and Hospital
- Health Parametrics Inc.
- New York State Health Foundation
- Jeffrey W. Clark, MD
- MingSight Pharmaceuticals Pty Limited
- Ionis Pharmaceuticals
- View Full List
Medical Conditions
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- HDT-AHCT
- Pancreatic Neoplasms
- Pregnancy-Related Condition, Unspecified
- H.Pylori Infection
- Hyperthyroidism, Autoimmune
- Brain MRI
- Locally Advanced NSCLC
- Renal Cancer Metastatic
- Periferal Arterial Occlusive Disease, PAOD
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Metastatic Spine Lesions
- Liver Hemangioma
- Waldenstrom's Macroglobulinemia Recurrent
- Primary Generalized Dystonia
- ACTH-Secreting Pituitary Adenoma
- Ascaris Suum
- Fasting, Diet, Chemotherapy, Toxicity
- Advanced Esophageal Cancers
- LSIL
- View Full List
Drug Interventions
- Ombrabulin (AVE8062)
- Pentostatin
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Toripalimab plus Anlotinib
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Fludarabine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Levcromakalim
- 200 µg doxorubicin-containing MNA
- Levobupivacaine, clonidine
- AZD7798
- Hydroxychloroquine
- Nimotuzumab
- Rifaximin
- Postoperative analgesia management
- ESK981
- Bendamustine
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- CKD-519
- View Full List
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Colombia
- Contract Research Organizations in Egypt
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in France
- Contract Research Organizations in Germany
- Contract Research Organizations in Latvia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Mexico
- Contract Research Organizations in Philippines
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Serbia
- CRO list by country